Alzheimer’s Association Research Roundtable

At a Glance
  • Status: Active Consortium
  • Year Launched: 2003
  • Initiating Organization: Alzheimer's Association
  • Initiator Type: Nonprofit foundation
  • Disease focus:
    Alzheimer's Disease
  • Location: North America

Abstract

The Alzheimer’s Association Research Roundtable is a consortium of scientists from the pharmaceutical, biotechnology, diagnostics, imaging, and cognitive testing industries, supported by Association senior staff and advisors. Its mission is to facilitate the development and implementation of new treatments for Alzheimer’s disease (AD) by collectively addressing obstacles to research and development, clinical care, and public health education.

Mission

Roundtable members seek to facilitate the development and implementation of new treatments for AD by collectively addressing obstacles to research and development, clinical care, and public health education.

Roundtable members explore a broad range of AD science topics, including

Consortium History

Established in 2003 with 4 sponsors, the Roundtable now includes more than 20 corporate sponsors, each of which sends several senior scientists to the Roundtable to benefit from the state-of-the-field scientific presentations, collegial interactions, and networking opportunities. Additional attendees include investigators from academia and government organizations such as the U.S. Food and Drug Administration and its European equivalent, the European Medicines Agency, and the National Institutes of Health.

Structure & Governance

Through the Roundtable, the Alzheimer’s Association brings together scientists from around the world to discuss key areas in AD science. The Roundtable convenes twice each year for a two-day presentation and discussion of specific topics within AD research. Topics are selected from a list proposed and voted on by members.

Once a topic is selected, a subcommittee consisting of Roundtable members and Association science staff extend invitations to speakers.

Data Sharing

The Roundtable makes its findings available via the Alzheimer’s Association’s journal.

Impact/Accomplishment

The outputs of Roundtable meetings are published as articles in the Alzheimer’s Association’s journal.

Points of Contact

Jay Thompson
Senior Associate Director Corporate Initiatives
phone: 312-335-5192
email: jay.thompson@alz.org

Sponsors & Partners

Abbvie

Amgen

Astellas

AstraZeneca

Biogen Idec

Boehringer Ingelheim

Bracket

Cytox

Eisai                                                 

Forest Research Institution

Forum Pharmaceuticals

GE Healthcare

Grifols                                                                

Janssen

Eli Lilly

Merck

Navidea Biopharmaceuticals

Novartis

Pfizer

Piramal Life Sciences

Psychology Software Tools

Roche

Sanofi

Takeda

Transition Therapeutics


Last Updated: 04/06/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.